WebTrilo Therapeutics is a seed-stage company focused on the discovery of novel inhibitors of protein-protein interactions for therapeutic purposes. Trilo Therapeutics headquarters is in San Francisco, California. Trilo Therapeutics is in the sectors of: Biotech. To connect with Trilo Therapeutics's employee register on Signalhire Email & Phone Finder WebOur Trilomer ® platform of peptidomimetic binders allows for the targeted inhibition of disease-causing proteins, for the treatment of cancer, autoimmune diseases, infectious … Prior to Trilo, he was Chief Scientific Officer at Oxford Biotherapeutics, and Director of …
Trilo Therapeutics - Crunchbase Company Profile & Funding
WebTrilo Therapeutics. Doctor of Philosophy. Contact. Connect with experts in your field. Join ResearchGate to contact this researcher and connect with your scientific community. Join for free. WebTrilo Therapeutics Mar 2024- Present5 years 2 months San Francisco Bay Area Assoc. Director II, Discovery AbbVie Jan 2013- Feb 20245 years 2 … medications that can cause sinus tachycardia
Trilo Therapeutics, Inc. Company Profile Belmont, CA
WebMay 20, 2024 · 4.22 Trilo Therapeutics 4.23 Ubiquigent 4.24 Ubix Therapeutics 5 Profiles of Major Pharmaceutical Companies with Stakes in TPD 5.1 AbbVie 5.2 Amgen 5.3 AstraZeneca 5.4 Bayer 5.5 Biogen 5.6... WebSep 15, 2024 · Trilo Therapeutics is focused on the discovery of novel inhibitors of protein-protein interactions for therapeutic purposes. Our Trilomer® platform of peptidomimetic … WebTRILO THERAPEUTICS, INC. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 953 Indiana St. San Francisco, CA 94107: Registered Agent: Kurt Gish: Filing Date: July 11, 2024: File Number: 4296942: Contact Us About The Company Profile For Trilo Therapeutics, Inc. medications that can cause syncope